|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01858 CHUNLI MEDICAL
Nominal 
() | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 511,714 | 41,008 | 164,786 | 260,682 |
| Net Cash from / (used in) Investing Activities | -- | (81,556) | (762,612) | (190,347) | (21,537) |
| Net Cash from / (used in) Financing Activities | -- | (121,334) | (59,036) | 1,073,663 | (11,876) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 308,824 | (780,640) | 1,048,102 | 227,270 |
| Cash & Cash Equivalents at beginning of period | -- | 957,194 | 1,736,494 | 690,116 | 464,177 |
| Effect of Foreign Exchange Rate Changes | -- | (4) | 1,340 | (1,724) | (1,331) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,266,013 | 957,194 | 1,736,494 | 690,116 |
| Remarks: | Real time quote last updated: -- |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 79,026,079 |
| %Change | -37.319% |
| EPS / (LPS) | RMB 0.210 |
| NBV Per Share (¥) | RMB 7.346 |